Posts tagged as:

geriatric medicine

Tweet- From LexisNexis® Mealey’s™ Daily Legal News. Par Pharmaceutical Cos. Inc. on March 5 pleaded guilty to misbranding its Megace ES anti-wasting drug by promoting it for off-label use in geriatric patients and will pay $ 45 million to resolve criminal and civil allegations, according to the U.S. Attorney’s Office for the District of New […]

{ 0 comments }